Graft function after autologous islet transplantation
Official title: Analysis of Graft Function Following Autologous Islet Transplantation
Run by Baylor Research Institute · NCT03097185 · Data updated 2026-11-12
We will see if measuring inflammatory markers in blood before and after total pancreatectomy with islet autotransplantation helps explain how well transplanted islet cells work in adults with chronic pancreatitis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Baylor Research Institute Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Status | Recruiting |
| Started | June 3, 2010 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | December 8, 2025 |
| Trial ID | NCT03097185 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with chronic pancreatitis who are scheduled for total pancreatectomy with or without islet autotransplantation and who can attend follow-up visits at Baylor are ideal candidates.
✕Probably not a fit
Patients who cannot attend required follow-up visits at Baylor or those with very advanced pancreatitis who are not suitable for TP-AIT are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will enroll 100 adults with chronic pancreatitis who are scheduled for total pancreatectomy with islet autotransplantation (TP-AIT) or total pancreatectomy (TP) alone at Baylor centers. Blood samples will be collected serially to measure inflammatory markers and blood-based indicators of islet graft function such as C-peptide and glucose control. The cohort includes up to 85 TP-AIT and 15 TP-alone participants and may include patients concurrently enrolled in a reparixin interventional protocol. Data will be analyzed to correlate perioperative inflammation with subsequent islet graft performance.
Why it matters
Potential benefit: If successful, the findings could help predict which patients will retain insulin-producing function after TP-AIT and guide personalized perioperative care.
How similar studies have gone: Previous observational work has linked inflammatory markers to islet transplant outcomes, but prospective biomarker profiling specifically around TP-AIT remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with chronic pancreatitis and who are scheduled for TP alone or TP-AIT 2. Patients aged 18 or older 3. Patients are able and willing to attend required follow-up visits at Baylor Exclusion Criteria: 1. Patients who are unable/unwilling to attend follow-up visits at Baylor 2. For TP-AIT subjects: Patients who have advanced stage of chronic pancreatitis. The principal investigator or co-investigators carefully review the medical charts, laboratory results and radiology department reports and determine the suitability for this study.
Where it's running
-
Baylor University Medical Center - Sammons Outpatient Cancer Center
Dallas, Texas, United States Recruiting
Study contacts
- Principal investigator: Ernest E Beecherl, MD — Sammons Cancer Center, Baylor University Medical Center
- Study coordinator: Anne M Jones, BSN, RN
- Email: anne.jones@bswhealth.org
- Phone: 214-820-7623
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CBT-248 safety in healthy adults for chronic pancreatitis support
This early study tests CBT-248 in healthy adults to see if it is safe, how it behaves in the body, and whether meals affect its levels.
-
Blood protein biomarkers to help diagnose pancreatic cancer in adults
This study tests whether blood protein biomarkers can help detect pancreatic ductal adenocarcinoma and tell it apart from chronic pancreatitis and mucinous pancreatic lesions, and whether combining markers with CA 19-9 improves accuracy.
-
Relieving a blocked pancreatic duct in chronic pancreatitis
This pilot study tests whether clearing a blocked pancreatic duct with endoscopy can help people with chronic pancreatitis who have mild symptoms.
-
Understanding brain changes in chronic pancreatitis pain
This study tests whether central nervous system changes and neuropsychological factors help explain persistent pain in adults with chronic pancreatitis.
-
EUS-guided pancreaticobiliary procedures with the RIVOS access device
This study tests how the RIVOS EUS access device performs during interventional procedures for pancreatic and bile duct problems in adults.
-
Odesa Criteria 2026: tests for autoimmune pancreatitis diagnosis
This study checks if the OC26 scoring system can accurately diagnose autoimmune pancreatitis in adults who may have AIP or related pancreatic diseases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.